How should statin therapy be monitored after initiation?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

How should statin therapy be monitored after initiation?

Monitoring statin therapy focuses on both confirming efficacy and ensuring safety. After starting a statin or changing the dose, check a lipid panel within about 4 to 12 weeks to see how much LDL-C has dropped and to assess adherence and tolerability. If the response is satisfactory and there are no safety concerns, you can space follow-up lipid testing out to every 3 to 12 months, depending on the patient’s risk, goals, and stability of response. Routine liver enzyme testing isn’t required for all patients; liver enzymes are checked if there are symptoms suggestive of hepatotoxicity or if there are specific risk factors or baseline abnormalities. If a patient develops muscle symptoms, consider checking CK and reassessing the therapy.

Monitoring statin therapy focuses on both confirming efficacy and ensuring safety. After starting a statin or changing the dose, check a lipid panel within about 4 to 12 weeks to see how much LDL-C has dropped and to assess adherence and tolerability. If the response is satisfactory and there are no safety concerns, you can space follow-up lipid testing out to every 3 to 12 months, depending on the patient’s risk, goals, and stability of response. Routine liver enzyme testing isn’t required for all patients; liver enzymes are checked if there are symptoms suggestive of hepatotoxicity or if there are specific risk factors or baseline abnormalities. If a patient develops muscle symptoms, consider checking CK and reassessing the therapy.

More practice questions